FDA OKs 99 per cent bacteria-killing wound dressing
Imbed Biosciences today received clearance from the Food and Drug Administration to market its patented wound dressing for human use. The dressing it calls Microlyte Ag is a sheet as thin as Saran Wrap and can conform to the bumps and crevices of a wound, says company CEO Ankit Agarwal.

The dressing is now cleared by the FDA as a class II medical device, for prescription and over-the-counter use.

Like many dressings now used to treat burns and other persistent wounds, Microlyte Ag contains silver to kill bacteria - but in much smaller quantities.


Read More:
http://www.eurekalert.org/pub_releases/2016-08/uow-us080516.php
Dr. U●●a D●●e and 8 others like this
Like
Comment
Share